Protalex's Unattributed VC - II Round

Protalex raised a round of funding on May 05, 2005. Investors include vSpring Capital.

Protalex (www.protalex.com) is a biotechnology company engaged in the development of a new class of immunomodulatory drugs for treatment of rheumatoid arthritis and other autoimmune diseases. The comp…

Articles about Protalex's Unattributed VC - II Round: